EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Nanocarriers for Combination Therapy in Pancreatic Ductal Adenocarcinoma: A Comprehensive Review

Iris Pontón iD, David Sánchez-García iD

Nanomaterials · 22.07.2025 · 15 (15) · 1139

DOI: 10.3390/nano15151139 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Nanomaterials, online erschienen am 22.07.2025. Verfasst von Iris Pontón und 1 weiteren Autor:innen. Beteiligte Einrichtung: Grup d'Enginyeria de Materials (GEMAT), Institut Químic de Sarrià (IQS), Universitat Ramon Llull (URL), Via Augusta 390, 08017 Barcelona, Spain. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 141 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Spanish Ministerio de Ciencia e Innovación, Agencia de Gestió d’Ajuts Universitaris i de Recerca (AGAUR) from Generalitat de Catalunya is also acknowledged.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pancreatic ductal adenocarcinoma (PDAC) remains one of the deadliest cancers worldwide, characterized by late diagnosis, aggressive progression, and poor response to conventional monotherapies. Combination therapies have emerged as a promising approach to overcome multidrug resistance (MDR), enhance efficacy, and target the complex tumor microenvironment (TME). Nanoparticle-based drug delivery systems (DDSs) have gained significant attention for their ability to co-deliver multiple agents with controlled release profiles. This review comprehensively examines nanoparticle-based platforms developed for PDAC combination therapies, focusing on small-molecule drugs. The systems discussed are drawn from studies published between 2005 and 2025.

Schlagwörter

Stichwörter der Autor:innen

chemotherapycombination therapymulti-drug resistancenanomedicinenanoparticlespancreatic cancerpancreatic ductal adenocarcinomastromal therapy

Autor:innen und Institutionen

  • Grup d'Enginyeria de Materials (GEMAT), Institut Químic de Sarrià (IQS), Universitat Ramon Llull (URL), Via Augusta 390, 08017 Barcelona, Spain.

ORCID-Profile: Iris Pontón, David Sánchez-García

Förderung

  • Spanish Ministerio de Ciencia e Innovación
  • Agencia de Gestió d’Ajuts Universitaris i de Recerca (AGAUR) from Generalitat de Catalunya is also acknowledged

Zitieren

APA

Pontón, I., & Sánchez-García, D. (2025). Nanocarriers for Combination Therapy in Pancreatic Ductal Adenocarcinoma: A Comprehensive Review. Nanomaterials, 15(15), 1139. https://doi.org/10.3390/nano15151139

Vancouver

Pontón I, Sánchez-García D. Nanocarriers for Combination Therapy in Pancreatic Ductal Adenocarcinoma: A Comprehensive Review. Nanomaterials. 2025;15(15):1139. doi:10.3390/nano15151139

BibTeX
@article{Pontn2025,
  author = {Pontón, Iris and Sánchez-García, David},
  title = {Nanocarriers for Combination Therapy in Pancreatic Ductal Adenocarcinoma: A Comprehensive Review},
  journal = {Nanomaterials},
  year = {2025},
  volume = {15},
  number = {15},
  pages = {1139},
  doi = {10.3390/nano15151139}
}
Kostenlos starten →